Logo image of TNON

TENON MEDICAL INC (TNON) Stock Fundamental Analysis

NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD

1.46  +0.44 (+43.14%)

After market: 1.355 -0.1 (-7.19%)

Fundamental Rating

3

Overall TNON gets a fundamental rating of 3 out of 10. We evaluated TNON against 187 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for TNON as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, TNON is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TNON had negative earnings in the past year.
TNON had a negative operating cash flow in the past year.
TNON had negative earnings in each of the past 5 years.
TNON had a negative operating cash flow in each of the past 5 years.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -102.38%, TNON is not doing good in the industry: 81.28% of the companies in the same industry are doing better.
With a Return On Equity value of -146.26%, TNON is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -102.38%
ROE -146.26%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Gross Margin of TNON (47.62%) is comparable to the rest of the industry.
TNON's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TNON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TNON has more shares outstanding
Compared to 5 years ago, TNON has more shares outstanding
TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -8.22, we must say that TNON is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of TNON (-8.22) is worse than 77.54% of its industry peers.
There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.22
ROIC/WACCN/A
WACC8.62%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

TNON has a Current Ratio of 5.46. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
TNON has a Current ratio of 5.46. This is in the better half of the industry: TNON outperforms 78.07% of its industry peers.
A Quick Ratio of 5.19 indicates that TNON has no problem at all paying its short term obligations.
The Quick ratio of TNON (5.19) is better than 80.21% of its industry peers.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 5.19
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 71.34% over the past year.
The Revenue has been growing slightly by 2.27% in the past year.
The Revenue has been growing by 130.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.9%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%0.97%

3.2 Future

Based on estimates for the next years, TNON will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.85% on average per year.
TNON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 57.36% yearly.
EPS Next Y91.76%
EPS Next 2Y40.01%
EPS Next 3Y25.42%
EPS Next 5Y14.85%
Revenue Next Year20.59%
Revenue Next 2Y41.59%
Revenue Next 3Y46.6%
Revenue Next 5Y57.36%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TNON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

TNON's earnings are expected to grow with 25.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.01%
EPS Next 3Y25.42%

More info and screens

0

5. Dividend

5.1 Amount

TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TENON MEDICAL INC

NASDAQ:TNON (8/1/2025, 8:06:46 PM)

After market: 1.355 -0.1 (-7.19%)

1.46

+0.44 (+43.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners2.05%
Inst Owner Change0%
Ins Owners0.28%
Ins Owner Change0%
Market Cap11.08M
Analysts82.5
Price Target5.95 (307.53%)
Short Float %0.45%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.38%
Min EPS beat(2)1.96%
Max EPS beat(2)10.79%
EPS beat(4)4
Avg EPS beat(4)9.14%
Min EPS beat(4)1.96%
Max EPS beat(4)15.97%
EPS beat(8)8
Avg EPS beat(8)20.07%
EPS beat(12)10
Avg EPS beat(12)-2.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.31%
Min Revenue beat(2)-47.97%
Max Revenue beat(2)-40.64%
Revenue beat(4)0
Avg Revenue beat(4)-29.61%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)-2.88%
Revenue beat(8)0
Avg Revenue beat(8)-24.33%
Revenue beat(12)0
Avg Revenue beat(12)-19.48%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)61%
EPS NY rev (1m)26.27%
EPS NY rev (3m)44.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-39.68%
Revenue NY rev (1m)-4.94%
Revenue NY rev (3m)-27.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.37
P/FCF N/A
P/OCF N/A
P/B 1.18
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-15.34
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-1.32
OCFYN/A
SpS0.43
BVpS1.24
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.38%
ROE -146.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.62%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.12%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.46
Quick Ratio 5.19
Altman-Z -8.22
F-Score4
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)391.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.9%
EPS Next Y91.76%
EPS Next 2Y40.01%
EPS Next 3Y25.42%
EPS Next 5Y14.85%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%0.97%
Revenue Next Year20.59%
Revenue Next 2Y41.59%
Revenue Next 3Y46.6%
Revenue Next 5Y57.36%
EBIT growth 1Y2.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.78%
OCF growth 3YN/A
OCF growth 5YN/A